Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
quizartinib
quizartinib
Medicine
Status
Monitoring
SPC
PIL
XPIL
Legal Category
Active Ingredient(s)
Company
vanflyta
SPC - EMA
quizartinib
Daiichi Sankyo Europe GmbH
VANFLYTA 17.7 mg film-coated tablets
New
SPC
PIL
Yes
B
quizartinib
Daiichi Sankyo Ireland Ltd
VANFLYTA 26.5 mg film-coated tablets
New
SPC
PIL
Yes
B
quizartinib
Daiichi Sankyo Ireland Ltd
Cookies
